Hyphens Pharma International Limited (SGX:1J5)

SGXC:1J5 Revenue

Hyphens Pharma International had revenue of 89.07M SGD in the half year ending June 30, 2026, a decrease of -10.62%. This brings the company's total for the last twelve months to 176.89M, down -4.55% year-over-year. In the year 2025, Hyphens Pharma International had annual revenue of 177.37M, down -9.24%. That makes Hyphens Pharma International the 20,205th largest company in the world by revenue and 199th in Singapore.

• Revenue (ttm): 176.89M
• Revenue Growth: -4.55%
• P/S Ratio: 0.61
• Revenue / Employee: 380.40K
• Employees: 474
• Market Cap: 108.12M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical and Medical Aesthetics 101.33M 57.1%
• Digital Platform and E-Pharmacy 39.37M 22.2%
• Proprietary Brands 36.67M 20.7%

By Geography

Chart

• Singapore 93.20M 52.5%
• Vietnam 39.53M 22.3%
• Malaysia 27.37M 15.4%
• Others 17.27M 9.7%

Fiscal year ended Dec 31, 2025 See the full SGXC:1J5 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	177.37M	-18.05M	-9.24%
Dec 31, 2024	195.42M	24.83M	14.55%
Dec 31, 2023	170.60M	8.28M	5.10%
Dec 31, 2022	162.32M	36.43M	28.94%
Dec 31, 2021	125.88M	4.91M	4.06%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 25, 2026

Data Sources Report a data error